Filtros de búsqueda

Lista de obras de Dena Howard

A platform trial in practice: adding a new experimental research arm to the ongoing confirmatory FLAIR trial in chronic lymphocytic leukaemia

artículo científico publicado en 2021

A randomized phase II trial of fludarabine, cyclophosphamide and mitoxantrone (FCM) with or without rituximab in previously treated chronic lymphocytic leukaemia

artículo científico publicado en 2011

Adding a treatment arm to an ongoing clinical trial: a review of methodology and practice ⬇️

artículo científico publicado en 2015

An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma

artículo científico publicado en 2007

Analysis of VHL Gene Alterations and their Relationship to Clinical Parameters in Sporadic Conventional Renal Cell Carcinoma

artículo científico publicado en 2009

Characterizing and quantifying the effects of breast cancer therapy using mathematical modeling ⬇️

artículo científico publicado en 2016

Clinical significance of DNA methylation in chronic lymphocytic leukemia patients: results from 3 UK clinical trials

scientific article published on 01 August 2019

Eradication of minimal residual disease improves overall and progression-free survival in patients with chronic lymphocytic leukaemia, evidence from NCRN CLL207: a phase II trial assessing alemtuzumab consolidation ⬇️

artículo científico publicado en 2016

Genetic and epigenetic analysis of von Hippel-Lindau (VHL) gene alterations and relationship with clinical variables in sporadic renal cancer

artículo científico publicado en 2006

Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival ⬇️

artículo científico publicado el 23 de junio de 2011

Proliferation index: a continuous model to predict prognosis in patients with tumours of the Ewing's sarcoma family ⬇️

artículo científico publicado en 2014

Results of the randomized phase IIB ARCTIC trial of low-dose rituximab in previously untreated CLL. ⬇️

artículo científico publicado en 2017

Rituximab plus chlorambucil as first-line treatment for chronic lymphocytic leukemia: Final analysis of an open-label phase II study

artículo científico publicado en 2014

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda